95 related articles for article (PubMed ID: 29864717)
1. Levels of retinal IAPP are altered in Alzheimer's disease patients and correlate with vascular changes and hippocampal IAPP levels.
Schultz N; Byman E; ; Wennström M
Neurobiol Aging; 2018 Sep; 69():94-101. PubMed ID: 29864717
[TBL] [Abstract][Full Text] [Related]
2. Levels of Retinal Amyloid-β Correlate with Levels of Retinal IAPP and Hippocampal Amyloid-β in Neuropathologically Evaluated Individuals.
Schultz N; Byman E; ; Wennström M
J Alzheimers Dis; 2020; 73(3):1201-1209. PubMed ID: 31884473
[TBL] [Abstract][Full Text] [Related]
3. Amylin alters human brain pericyte viability and NG2 expression.
Schultz N; Byman E; Fex M; Wennström M
J Cereb Blood Flow Metab; 2017 Apr; 37(4):1470-1482. PubMed ID: 27354094
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E Interferes with IAPP Aggregation and Protects Pericytes from IAPP-Induced Toxicity.
Gharibyan AL; Islam T; Pettersson N; Golchin SA; Lundgren J; Johansson G; Genot M; Schultz N; Wennström M; Olofsson A
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31947546
[TBL] [Abstract][Full Text] [Related]
5. Identification of early pericyte loss and vascular amyloidosis in Alzheimer's disease retina.
Shi H; Koronyo Y; Rentsendorj A; Regis GC; Sheyn J; Fuchs DT; Kramerov AA; Ljubimov AV; Dumitrascu OM; Rodriguez AR; Barron E; Hinton DR; Black KL; Miller CA; Mirzaei N; Koronyo-Hamaoui M
Acta Neuropathol; 2020 May; 139(5):813-836. PubMed ID: 32043162
[TBL] [Abstract][Full Text] [Related]
6. Microvascular network alterations in the retina of patients with Alzheimer's disease.
Cheung CY; Ong YT; Ikram MK; Ong SY; Li X; Hilal S; Catindig JA; Venketasubramanian N; Yap P; Seow D; Chen CP; Wong TY
Alzheimers Dement; 2014 Mar; 10(2):135-42. PubMed ID: 24439169
[TBL] [Abstract][Full Text] [Related]
7. Islet Amyloid Polypeptide Promotes Amyloid-Beta Aggregation by Binding-Induced Helix-Unfolding of the Amyloidogenic Core.
Ge X; Yang Y; Sun Y; Cao W; Ding F
ACS Chem Neurosci; 2018 May; 9(5):967-975. PubMed ID: 29378116
[TBL] [Abstract][Full Text] [Related]
8. In vivo seeding and cross-seeding of localized amyloidosis: a molecular link between type 2 diabetes and Alzheimer disease.
Oskarsson ME; Paulsson JF; Schultz SW; Ingelsson M; Westermark P; Westermark GT
Am J Pathol; 2015 Mar; 185(3):834-46. PubMed ID: 25700985
[TBL] [Abstract][Full Text] [Related]
9. Hippocampal capillary pericytes in post-stroke and vascular dementias and Alzheimer's disease and experimental chronic cerebral hypoperfusion.
Hase Y; Jobson D; Cheong J; Gotama K; Maffei L; Hase M; Hamdan A; Ding R; Polivkoski T; Horsburgh K; Kalaria RN
Acta Neuropathol Commun; 2024 Feb; 12(1):29. PubMed ID: 38360798
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition.
Adler BL; Yarchoan M; Hwang HM; Louneva N; Blair JA; Palm R; Smith MA; Lee HG; Arnold SE; Casadesus G
Neurobiol Aging; 2014 Apr; 35(4):793-801. PubMed ID: 24239383
[TBL] [Abstract][Full Text] [Related]
11. Contraction of human brain vascular pericytes in response to islet amyloid polypeptide is reversed by pramlintide.
Nuñez-Diaz C; Pocevičiūtė D; Schultz N; ; Welinder C; Swärd K; Wennström M
Mol Brain; 2023 Feb; 16(1):25. PubMed ID: 36793056
[TBL] [Abstract][Full Text] [Related]
12. Retinal microvasculature in Alzheimer's disease.
Cheung CY; Ong YT; Ikram MK; Chen C; Wong TY
J Alzheimers Dis; 2014; 42 Suppl 4():S339-52. PubMed ID: 25351108
[TBL] [Abstract][Full Text] [Related]
13. Retinal vascular and structural changes are associated with amyloid burden in the elderly: ophthalmic biomarkers of preclinical Alzheimer's disease.
Golzan SM; Goozee K; Georgevsky D; Avolio A; Chatterjee P; Shen K; Gupta V; Chung R; Savage G; Orr CF; Martins RN; Graham SL
Alzheimers Res Ther; 2017 Mar; 9(1):13. PubMed ID: 28253913
[TBL] [Abstract][Full Text] [Related]
14. Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro.
Podestà F; Romeo G; Liu WH; Krajewski S; Reed JC; Gerhardinger C; Lorenzi M
Am J Pathol; 2000 Mar; 156(3):1025-32. PubMed ID: 10702418
[TBL] [Abstract][Full Text] [Related]
15. Ocular indicators of Alzheimer's: exploring disease in the retina.
Hart NJ; Koronyo Y; Black KL; Koronyo-Hamaoui M
Acta Neuropathol; 2016 Dec; 132(6):767-787. PubMed ID: 27645291
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 in the hippocampal vasculature: pathological synergy of Alzheimer's disease and diabetes mellitus.
Valente T; Gella A; Solé M; Durany N; Unzeta M
J Neurosci Res; 2012 Oct; 90(10):1989-96. PubMed ID: 22714978
[TBL] [Abstract][Full Text] [Related]
17. Hyperspectral imaging signatures detect amyloidopathy in Alzheimer's mouse retina well before onset of cognitive decline.
More SS; Vince R
ACS Chem Neurosci; 2015 Feb; 6(2):306-15. PubMed ID: 25354367
[TBL] [Abstract][Full Text] [Related]
18. Toluidine blue O modifies hippocampal amyloid pathology in a transgenic mouse model of Alzheimer's disease.
Yuksel M; Biberoglu K; Onder S; Akbulut KG; Tacal O
Biochimie; 2018 Mar; 146():105-112. PubMed ID: 29248542
[TBL] [Abstract][Full Text] [Related]
19. BRICHOS domain of Bri2 inhibits islet amyloid polypeptide (IAPP) fibril formation and toxicity in human beta cells.
Oskarsson ME; Hermansson E; Wang Y; Welsh N; Presto J; Johansson J; Westermark GT
Proc Natl Acad Sci U S A; 2018 Mar; 115(12):E2752-E2761. PubMed ID: 29507232
[TBL] [Abstract][Full Text] [Related]
20. Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus.
Jeong HR; An SS
Clin Interv Aging; 2015; 10():1873-9. PubMed ID: 26604727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
